Johnson & Johnson announced Aug. 23 that it would be fundamentally changing the way it makes 340B pricing available for two of its most popular products, Stelara and Xarelto.
The Health Resources and Services Administration announced Aug. 20 $1.4 billion in program funding for individuals with HIV who have low incomes to receive medication, health care and support services.
The Department of Health and Human Services Health Sector Cybersecurity Coordination Center (HC3) this week released an advisory about Everest, a ransomware-as-a-service group increasingly targeting the health care field.
A Texas federal court Aug. 20 ruled set aside the Federal Trade Commission’s Non-Compete Clause Final Rule. U.S. District Judge Ada Brown held the FTC lacked the authority to enact the rule, which would ban, as an unfair method of competition, contractual terms that prohibit workers from pursuing certain employment after their contract with an employer ends.
The Centers for Disease Control COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest it has been since January 2022.
The Centers for Medicaid and Medicare Services Aug. 20 released a report presenting data on complaints and enforcement efforts by the agency concerning title XXVII of the Public Health Service Act, which includes both the surprise billing and price transparency provisions of the No Surprises Act.
Boston Medical Center is the winner of the AHA’s 2024 Foster G. McGaw Prize, which recognizes the efforts of hospitals and health systems to improve the health and well-being of their communities.
The Centers for Disease Control Aug. 16 issued an advisory to clinicians and public health officials warning of increased Oropouche virus disease, which insects like mosquitos transmit.
The latest Arnold Ventures-backed report from Third Way uses flawed tools and data to push a false narrative about the critical role hospitals and health systems play for the patients and communities they serve, according to an AHA blog published Aug. 16.
The World Health Organization Aug. 14 declared a global health emergency due to the recent mpox outbreak in Africa, the second mpox declaration in two years.
The Centers for Medicare & Medicaid Aug. 15 announced it negotiated lower prices with drug makers for 10 high-cost, sole-source drugs, with the new prices becoming effective in 2026 for individuals with Medicare Part D coverage.
In the latest "Safety Speaks" conversation, Christi Barney, R.N., vice president of quality and patient safety at Emerson Health, discusses the health system’s innovative approach to culture building, and how quality and safety trainings for all stakeholders drove buy-in and measurable success.
The AHA, joined by five other national hospital associations, Aug. 14 filed an amicus brief urging the Supreme Court to correct the Department of Health and Human Services’ misinterpretation of the formula set by Congress to calculate Disproportionate Share Hospital (DSH) payments, which includes a Medicare fraction that counts supplemental security income-eligible Medicare beneficiaries in the numerator and the total Medicare-eligible population in the denominator.